Deal Library / Pharma BD Deal Intelligence

Boehringer Ingelheim International GmbH — Pharma Deals

The Pharma Closeout tracks 5 deals, $14.0B in disclosed deal value, 1 with a post-close Outcome Score for Boehringer Ingelheim International GmbH.

Median Critic Score: 78  ·  Median Outcome Score: 81

All 5 deals

• Boehringer Ingelheim International GmbH / Sanofi SA (Merial Animal Health) — 2015 · $12.4B · Worked — the deal delivered on its rationale.
• Boehringer Ingelheim International GmbH / T3 Pharmaceuticals AG — 2023 · $508M
• Boehringer Ingelheim International GmbH / Ginkgo Bioworks Holdings, Inc. — 2023 · $405M
• Boehringer Ingelheim International GmbH / Abexxa Biologics Inc. — 2021
• Boehringer Ingelheim International GmbH / Hanmi Pharmaceutical Co., Ltd. (HM61713 program) — 2015 · $730M

← Deal Library  ·  Interactive search  ·  How we score deals